effectiveness of integrated transdiagnostic therapy

Investigating the pattern of transdiagnostic related to emotion regulation of adolescents with high-risk behavior and effectiveness of integrated transdiagnostic therapy on reduction of their anxiety, depression, and emotional dysregulation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230128057255N1

Enrollment

Registered

2023-06-27

Start date

2023-08-03

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Anxiety. Condition 2: Depression. Condition 3: Emotional dysregulation. Anxiety disorder, unspecified Depressive episode Emotional disorders with onset specific to childhood

Interventions

Intervention 1: Control group: Patients do not receive any intervention during the 12 weeks. Intervention 2: Intervention group: Patients receive 1 30-minute tranactional training session every week f

Eligibility

Sex/Gender

All

Age

12 Years to 17 Years

Inclusion criteria

Inclusion criteria: Diagnosis of anxiety based on Diagnostic and Statistical Manual of Mental Disorders (DSM) No use of Vitamin D3 before the study Lack of any psychotherapy during last 2 months

Exclusion criteria

Exclusion criteria: seizure Systolic blood pressure over 12 Drug allergy

Design outcomes

Primary

Measure	Time frame
Anxiety symptoms. Timepoint: Assessment of anxiety at the beginning of the study (before the intervention), weeks 4, 8 and 12. Method of measurement: Beck Anxiety Inventory.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMeysam Nikdanesh

Iran University of Medical Sciences

meysamnikdanesh@gmail.com+98 919 484 9599

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026